Create
Log in
Sign up
Golden has been acquired by ComplyAdvantage.
Read about it here ⟶
Aldeyra Therapeutics
Aldehyde-trap therapies
Overview
Structured Data
Issues
Contributors
Activity
Access by API
Access by API
Is a
Organization
Company
AngelList URL
angel.co/aldeyra-therapeutics
Board of Directors
Richard Douglas
0
Todd C. Brady
0
Neal Walker
0
CEO
Todd C. Brady
0
CFO
Bruce Greenberg
0
CIK Number
1,341,235
0
Legal Name
Aldeyra Therapeutics, Inc.
Company Operating Status
Active
Contact Page URL
aldeyra.com/contact/
Country
United States
Crunchbase URL
crunchbase.com/organiz...apeutics
Email Address
lroth@theruthgroup.com
Facebook URL
@aldeyratherapeutics
Fax Number
(339) 674-6495
0
Founded Date
2004
Full Address
131 Hartwell Avenue, Suite 320 Lexington, MA 02421, USA
0
Industry
Eye health technology
Dry eye syndrome
Biotechnology
Biology
Technology
Biomedical engineering
Engineering
Investors
Hercules Capital
Latest Funding Round Date
April 2021
Latest Funding Round Amount (USD)
125,000,000
LinkedIn URL
@company/aldeyra-therapeutics
Location
Lexington, Massachusetts
0
Number of Employees
14
0
Number of Employees (Ranges)
11 – 50
Patents Assigned (Count)
21
Phone Number
+17817614904
0
Pitchbook URL
pitchbook.com/profiles.../52767-37
Place of Incorporation
Delaware
0
Previous Name
Aldexa Therapeutics, Inc.
0
Neuron Systems Inc
0
SIC Code
2,834
0
Exchange
Nasdaq
0
Stock Symbol
ALDX
0
Ticker Symbol
ALDX
Total Funding Amount (USD)
267,500,000
Twitter URL
@aldeyraaldx
Official Website
aldeyra.com
Wellfound ID
aldeyra-therapeutics
Find more companies like Aldeyra Therapeutics
Use the Golden Query Tool to find similar companies in the same industry, location, or by any other field in the Knowledge Graph.
Open Query Tool
Access by API
Company
Home
Press & Media
Blog
Careers
WE'RE HIRING
Products
Knowledge Graph
Query Tool
Data Requests
Knowledge Storage
API
Pricing
Enterprise
ChatGPT Plugin
Legal
Terms of Service
Enterprise Terms of Service
Privacy Policy
Help
Help center
API Documentation
Contact Us
By using this site, you agree to our
Terms of Service
.
SUBSCRIBE